Peritoneal Mesothelioma Chemotherapy Treatment

Most cancer chemotherapy is applied systemically, meaning it is applied to your whole body via the circulatory system. The easiest way to deliver systemic chemotherapy for mesothelioma is to ingest it in pill or liquid form via the digestive system. This approach works only for those chemicals that can survive the rigors of being digested in the stomach, and then only if the molecules are small enough to be absorbed into the circulatory system by the intestines. Other common questions about chemotherapy as a part of mesothelioma treatment include:

What to Expect from Chemotherapy Treatment

Chemotherapy in mesothelioma treatment is not curative. That is not to say that chemotherapy is not without benefit to the patient affected by mesothelioma. Studies have demonstrated that the most active regimen can reduce tumors in 40% of patients and extend life in those that respond to chemotherapy. Chemotherapy has also been shown to palliate symptoms including reducing shortness of breath, reduction of ascites or effusions, reduction of pain and improvement has been noted in quality of life studies. Chemotherapy is also given as a neo adjuvant treatment (prior to a planned surgical intervention) post-surgery (adjuvant therapy) or as a single modality. In some cases patient who have been considered inoperable can become surgical candidates following administration of chemotherapy.

Some chemotherapy is cytotoxic which means that it is capable of killing malignant cells, others are cytostatic which means that it can inhibit cellular activity or cellular multiplication. We now use a new term “targeted” therapy or “smart” drugs which refers to drugs that are specifically designed to act on genes that promote or suppress cancerous cells. Immunotherapy is a method of harnessing the body’s own immune system to activate and kill malignant cells. A thorough discussion will take place in a section titled "Standard and Investigational Therapies in Mesothelioma”

Chemotherapy for mesothelioma is most often administered via a vein accessed by a small needle. Some chemotherapy comes in pill form. Whichever way it is administered it is systemic which means that it is meant to attack the cancer in his primary location as well as metastatic deposits. Some patients mistakenly believe that because a drug is given in a pill form that it is not as potent as an iv formulation. Side effects of chemotherapy are also not indicative of strength and patients reports of tolerance differ considerably. It can be the way a patient metabolizes a drug, a genetic alteration or past medical condition that can dictate how tolerable a drug will be to the individual. Different drugs have different effects on the body and some are more severe than others. Responses to chemotherapeutic drugs do not correlate with the severity of symptoms.

The molecular structures of many chemotherapy agents are too fragile to allow the drug to be taken this way, or they are too large to be absorbed into the blood stream through the intestines. Therefore, most chemotherapies are given by an injection or an intravenous drip along with saline solution on a specific timetable. Your entire body is therefore exposed to the effects of a systemic poison and not just the cancer in a specific location. This can be an important benefit of a systemic treatment if the cancer has already metastasized and begun to move to secondary areas or other organs. Once in the blood stream, the chemical agents can go wherever your circulatory system can reach.

Since organs like the brain, kidneys, lungs, and liver are also exposed to the toxic effects of these drugs, dosages need to be carefully controlled so as not to kill healthy cells along with the cancer cells. Antidotes can also be given in advance for some chemotherapy agents that are known to carry high risks of morbidity to organs like the kidneys or liver. Since excreting these systemic poisons as quickly as possible is important, having healthy kidneys may dictate whether chemotherapy is an option.

Localized Chemotherapy Treatment

The most effective alternative to systemic application is a regional or localized application where higher doses of the drugs can be administered directly to the affected area or organ. There are two variations to this technique of controlling the application of chemotherapy to specific surfaces. The first method is direct application and the second is intra-cavitary application via a special shunt or tube that is used to feed the chemicals directly into the peritoneal space. Both of these techniques allow much higher doses of chemicals to be used since most of the drug remains outside of the bloodstream, coating only the exposed tissue surfaces.

Some absorption of the chemo into the affected surfaces is necessary for it to work. For chemotherapy given in this manner during surgery, the surgeon will sometimes take tissue samples to analyze how deeply the drug has penetrated the tissue wall. Since penetration of the cell wall implies some entry of chemo into the bloodstream, the use of an antidote is an important precaution.

Which mesothelioma treatment approach is used depends upon the goals of the treatment and the need to control side effects. In any case, the application methods are carefully selected to ensure that more damage happens to the cancer cells than to the healthy cells. Chemotherapy works because the rapid growth of cancer cells makes them more vulnerable to chemicals that block, destroy or interfere with fast growing cells.

If you are in search of support, guidance or specialized information, the Mesothelioma Foundation is here to help. Talk to a mesothelioma expert for more specific, specialized information on peritoneal mesothelioma treatment.

Believe in a Cure!

Contact us here for immediate expert help and a free copy of the book "100 Questions & Answers About Mesothelioma."

(877) END-MESO
(877) 363-6376